PF-03800130

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePF-03800130
Drug Alias Namedual dopamine D2 partial agonist/serotonin reuptake inhibitor (Pfizer)PF-03800130
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor partial agonistsSerotonin reuptake inhibitors
TargetsDopamine D2 receptorSerotonin transporter
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaBipolar Disorder

Other Information

ATC CodeN/A
Related LinksN/A